Pancreatic Cancer Research

ResearcherFirst Hospital of Jilin UniversityActive in the last 2 years

Guoyue Lv

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4656-4955; OpenAlex author ID A5075808008. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Insights into artificial intelligence-based digital pathology in hepatobiliary and pancreatic cancer. Last author DOI 10.3389/fonc.2026.1871770↗
  2. Textbook Outcome, but Not Hospital Volume, Was Independently Associated with Survival after Resection for Pancreatic Cancer: A Statistical Trick? Last author DOI 10.1097/xcs.0000000000000746↗
  3. Comprehensive Analysis on Prognosis and Immune Infiltration of Lysyl Oxidase Family Members in Pancreatic Adenocarcinoma With Experimental Verification. Co-author DOI 10.3389/fmolb.2022.778857↗
  4. Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.13269↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. He-Yu Huang · 1 shared paper, 2026 · strength 0.43
  2. Da-Qun Liu · 1 shared paper, 2023 · strength 0.26
  3. Chao Jiang · 1 shared paper, 2022 · strength 0.19
  4. Guangyi Wang · 1 shared paper, 2022 · strength 0.19
  5. Wei Feng · 1 shared paper, 2016 · strength 0.06
  6. Yan Liu · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.